Kubo H - Search Results

1

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG. Stacker SA, et al. Among authors: kubo h. Nat Med. 2001 Feb;7(2):186-91. doi: 10.1038/84635. Nat Med. 2001. PMID: 11175849

2

Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, Kubo H, Stacker SA, Achen MG. Baldwin ME, et al. Among authors: kubo h. Mol Cell Biol. 2005 Mar;25(6):2441-9. doi: 10.1128/MCB.25.6.2441-2449.2005. Mol Cell Biol. 2005. PMID: 15743836 Free PMC article.

3

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, Ylä-Herttuala S, Alitalo K. Mäkinen T, et al. Among authors: kubo h. Nat Med. 2001 Feb;7(2):199-205. doi: 10.1038/84651. Nat Med. 2001. PMID: 11175851

4

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.

Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K. Veikkola T, et al. Among authors: kubo h. EMBO J. 2001 Mar 15;20(6):1223-31. doi: 10.1093/emboj/20.6.1223. EMBO J. 2001. PMID: 11250889 Free PMC article.

5

Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.

Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, Jackson DG, Yla-Herttuala S, Alitalo K. Enholm B, et al. Among authors: kubo h. Circ Res. 2001 Mar 30;88(6):623-9. doi: 10.1161/01.res.88.6.623. Circ Res. 2001. PMID: 11282897

6

VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW. Yoon YS, et al. Among authors: kubo h. J Clin Invest. 2003 Mar;111(5):717-25. doi: 10.1172/JCI15830. J Clin Invest. 2003. PMID: 12618526 Free PMC article.

7

Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis.

Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, Awane M, Sakai Y, Takabayashi A, Alitalo K, Yamaoka Y, Nishikawa SI. Kubo H, et al. Blood. 2000 Jul 15;96(2):546-53. Blood. 2000. PMID: 10887117 Free article.

8

Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.

Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Ylä-Herttuala S, Jäättelä M, Alitalo K. Karpanen T, et al. Among authors: kubo h. Cancer Res. 2001 Mar 1;61(5):1786-90. Cancer Res. 2001. PMID: 11280723

9

Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

Kubo H, Cao R, Brakenhielm E, Mäkinen T, Cao Y, Alitalo K. Kubo H, et al. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8868-73. doi: 10.1073/pnas.062040199. Epub 2002 Jun 17. Proc Natl Acad Sci U S A. 2002. PMID: 12070340 Free PMC article.

10

Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability.

Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Cao R, et al. Among authors: kubo h. Circ Res. 2004 Mar 19;94(5):664-70. doi: 10.1161/01.RES.0000118600.91698.BB. Epub 2004 Jan 22. Circ Res. 2004. PMID: 14739162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,408 results

Search Page

Filters